Dave Chonette is among the device industry's pioneers, having helped build both large companies--notably, Edwards Lifesciences--and the venture-based innovation model for creating start-ups to provide a continuing source of new products. This interview is adapted from a presentation at the 2007 Phoenix Medical Device CEOs conference, at which Chonette received the group's Lifetime Achievement award.
by Stephen Levin
The device industry’s business model of having a few large companies that dominate distribution channels and are fed innovative new...
Join thousands of industry professionals who rely on In Vivo for daily insights
Already a subscriber?
MedTech Forum 2025 was less MDR-focused than in previous years, as macro issues and exogenous threats were forced further into the center of medtech business thinking.
In a conversation with In Vivo, CEO Jon Congleton discusses Mineralys’s data-rich journey toward an NDA filing, the significance of recent trial wins and how its candidate may offer a dual benefit in blood pressure and renal protection.
Qubit Pharmaceuticals and Sorbonne University launched a quantum AI model that could slash drug synthesis requirements and enable exploration of previously undruggable targets.
